top of page
Report Summary
Market Overview

Global Pneumonia Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Pneumonia Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Product Type (Consumable, and Analyzer), Method Type (Immunodiagnostic, Molecular Diagnostic, and Point-of-Care (POC) Testing), Technology (Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Polymerase Chain Reaction, and Others), End-user (Hospitals, Diagnostic Centers, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Pneumonia Testing Market was valued at USD 1,891.5 million in 2023 and is expected to reach USD 3,274.3 million by 2031 while growing at a CAGR of 7.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global pneumonia testing market growth. Prompt and accurate diagnosis of pneumonia, a respiratory infection characterized by inflammation of the air sacs in one or both lungs, involves pneumonia testing. This diagnostic process aims to identify the presence of pneumonia, which can be caused by various infectious agents such as bacteria, viruses, fungi, and other microorganisms. This timely identification is crucial for initiating suitable treatment and preventing potential complications.


Resistant pathogens and public health surveillance boost the pneumonia testing market, while interference from colonizing flora and antibiotic stewardship could impede its growth.


Furthermore, the global pneumonia testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Product Type Analysis


The Global Pneumonia Testing Market is segmented among Consumable, and Analyzer, based on Product. In 2023, Analyzer accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Method Type Analysis


The Global Pneumonia Testing Market is segmented among Immunodiagnostic, Molecular Diagnostic, and Point-of-Care (POC) Testing, based on Type. In 2023, Point-of-Care (POC) Testing accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Pneumonia Testing Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott, Bio-Rad Laboratories, Inc., BioMérieux SA, Becton, Dickinson and Company, Curetis, Hologic Inc., Meridian Bioscience, Thermo Fisher Scientific, and Quidel Corporation


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Pneumonia Testing Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Pneumonia Testing Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Pneumonia Testing Market Segmentation, By Product Type

  • Global Pneumonia Testing Market Share Analysis, By Product Type

  • Global Pneumonia Testing Market Growth Analysis, By Product Type

  • Global Pneumonia Testing Market Trends, By Product Type

o Consumable

o Analyzer

6. Global Pneumonia Testing Market Segmentation, By Method Type

  • Global Pneumonia Testing Market Share Analysis, By Method Type

  • Global Pneumonia Testing Market Growth Analysis, By Method Type

  • Global Pneumonia Testing Market Trends, By Method Type

o Immunodiagnostic

o Molecular Diagnostic

o Point-of-Care (POC) Testing

7. Global Pneumonia Testing Market Segmentation, By Technology

  • Global Pneumonia Testing Market Share Analysis, By Technology

  • Global Pneumonia Testing Market Growth Analysis, By Technology

  • Global Pneumonia Testing Market Trends, By Technology

o Enzyme-linked immunosorbent Assay (ELISA)

o Immunofluorescence

o Immunohistochemistry (IHC)

o Polymerase Chain Reaction (PCR)

o Others

8. Global Pneumonia Testing Market Segmentation, By End-user

  • Global Pneumonia Testing Market Share Analysis, By End-user

  • Global Pneumonia Testing Market Growth Analysis, By End-user

  • Global Pneumonia Testing Market Trends, By End-user

o Hospitals

o Diagnostic Centers

o Others

9. Global Pneumonia Testing Market Segmentation, By Region

  • Global Pneumonia Testing Market Share Analysis, By Region

  • Global Pneumonia Testing Market Growth Analysis, By Region

  • Global Pneumonia Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

  • Abbott*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Bio-Rad Laboratories, Inc.

  • BioMérieux SA

  • Becton, Dickinson and Company

  • Curetis

  • Hologic Inc.

  • Meridian Bioscience

  • Thermo Fisher Scientific

  • Quidel Corporation

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page